Gold nanoparticles useful in treating lung cancer finds study

08 Aug 2017

1

A recent study has shown that gold could boost the effectiveness of drugs used to treat lung cancer cells. The Independent reported that the precious metal increased the effectiveness of drugs used to treat lung cancer cells.

The research team encased minute fragments called gold nanoparticles, in a chemical device.

While this has not yet been tested on humans, it is hoped that a device of the kind could one day be used to reduce side effects of current chemotherapy treatments by precisely targeting diseased cells without damaging healthy tissue.

Gold is a safe chemical element and can accelerate, or catalyse, chemical reactions. The scientists discovered properties of the metal that allowed these catalytic abilities to be accessed in living things without any side effects.

The device has been shown to be effective after its implantation in the brain of a zebrafish, suggesting it can be used in living animals. The study was carried out in collaboration with researchers at the University of Zaragoza's Institute of Nanoscience of Aragon in Spain, which was funded by Cancer Research UK (CRUK), and the Engineering and Physical Sciences Research Council.

Dr Asier Unciti-Broceta, from the University of Edinburgh's CRUK Edinburgh Centre, said, "We have discovered new properties of gold that were previously unknown and our findings suggest that the metal could be used to release drugs inside tumours very safely.''

A package could be developed to target only the diseased and cancerous cells and leaving the healthy cells alone, drastically cutting the harmful and potentially life threatening side effects of chemotherapy as we know it today.

According to Dr Unciti-Broceta, gold was not known to have this property of a delivery metal that could carry the chemotherapy drugs directly into the tumour and thus prevent it from affecting the healthy cells in its path of travel. But he called it a ''step forward''.

This could lead to a technology in future where a device could be made that could go directly into the tumour with the doctor being able to control the release of the drug into the tumour alone, according to experts.

Latest articles

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Indians can now travel to 56 destinations without prior visa as passport ranking improves

Indians can now travel to 56 destinations without prior visa as passport ranking improves

CEO says EU’s IRIS2 must match Starlink on price and performance

CEO says EU’s IRIS2 must match Starlink on price and performance

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Opening the silos: India approves 3 million tonnes of wheat and product exports

Opening the silos: India approves 3 million tonnes of wheat and product exports

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round